Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

about

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Item

http://www.wikidata.org/entity/Q57491552

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@en

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@nl

type

Item

label

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@en

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@nl

prefLabel

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@en

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@nl

P1476

Inflammatory Arthritis Induced ...... d Neck Squamous Cell Carcinoma

@en

P2093

Amanda Psyrri

http://www.w3.org/2001/XMLSchema#string

Antonis Fanouriakis

http://www.w3.org/2001/XMLSchema#string

Dimitra Kassara

http://www.w3.org/2001/XMLSchema#string

Ioannis Kotsantis

http://www.w3.org/2001/XMLSchema#string

Myrto Cheila

http://www.w3.org/2001/XMLSchema#string

Nikolaos Spathas

http://www.w3.org/2001/XMLSchema#string

Panagiota Economopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.

Immune-mediated adverse drug reactions.

Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature.

Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma.

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.

Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity.

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.

P304

409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.3389/FONC.2018.00409

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30319973

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6168664

http://www.w3.org/2001/XMLSchema#string